Umikibart

N/A

Report date: 2026/03/12 20:00:16

Base Information

Drug NameUmikibart
Drug Alias NameYYB-101NOV-1105CLM-101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionHepatocyte growth factor inhibitors
TargetsHepatocyte growth factor
Therapy Area/IndicationsSolid tumoursColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesYooYoung Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A